What You Should Know:
- Ascensia Diabetes Care, a global diabetes care company, maker of the CONTOUR® blood glucose monitoring (BGM) system portfolio and exclusive distributor of Eversense® Continuous Glucose Monitoring (CGM) Systems, has launched its online diabetes management and analytics platform GlucoContro.online in the United States.
- Now available in more than 15 countries globally and in the process of further expansion, GlucoContro.online support diabetes management by
Read More
CONTOUR®DIABETES app
Data-Driven Future: Impact of Machine Learning on Diabetes Management
“Information technology and business are becoming inextricably interwoven. I don't think anybody can talk meaningfully about one without the talking about the other” – Bill Gates wrote this in 1999 and, nowadays, the same can certainly be said about information technology and healthcare.
The ability to collect, analyze, and use data is becoming ubiquitous with many of healthcare’s most exciting advancements. Whether it’s Google’s DeepMind using artificial intelligence (AI) to help
Read More
Ascensia Diabetes Care Launches New Version of CONTOUR®DIABETES App to Support Self-Management
Today, Ascensia Diabetes Care has announced the launch of its upgraded version of the CONTOUR®DIABETES app in the United States. This latest version includes the new My Patterns feature, which uses innovative algorithms to more intelligently analyze blood glucose results received from the CONTOUR®NEXT ONE meter, and delivers personalized meaningful feedback to patients. This feedback is designed to help patients improve diabetes self-management and maintain positive lifestyle changs. This new
Read More
